Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients

被引:0
|
作者
Chunnan Liu
Zhaopei Liu
Kaifeng Jin
Han Zeng
Fei Shao
Yuan Chang
Yiwei Wang
Le Xu
Zewei Wang
Yu Zhu
Weijuan Zhang
机构
[1] Fudan University Shanghai Cancer Center,Department of Urology
[2] Fudan University,Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[3] Fudan University,Department of Urology, Zhongshan Hospital
[4] Shanghai Jiao Tong University School of Medicine,Department of Oncology, Shanghai General Hospital
[5] Shanghai Jiao Tong University School of Medicine,Department of Urology, Shanghai Ninth People’s Hospital
[6] Shanghai Jiao Tong University School of Medicine,Department of Urology, Ruijin Hospital
[7] Fudan University,Department of Immunology, School of Basic Medical Sciences
来源
British Journal of Cancer | 2022年 / 127卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1718 / 1725
页数:7
相关论文
共 50 条
  • [1] Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients
    Liu, Chunnan
    Liu, Zhaopei
    Jin, Kaifeng
    Zeng, Han
    Shao, Fei
    Chang, Yuan
    Wang, Yiwei
    Xu, Le
    Wang, Zewei
    Zhu, Yu
    Zhang, Weijuan
    BRITISH JOURNAL OF CANCER, 2022, 127 (09) : 1718 - 1725
  • [2] TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
    Liu, Zhaopei
    Zeng, Han
    Jin, Kaifeng
    Yu, Yanze
    You, Runze
    Zhang, Hongyi
    Liu, Chunnan
    Su, Xiaohe
    Yan, Sen
    Chang, Yuan
    Liu, Li
    Xu, Le
    Xu, Jiejie
    Zhu, Yu
    Wang, Zewei
    BRITISH JOURNAL OF CANCER, 2022, 126 (09) : 1310 - 1317
  • [3] TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
    Zhaopei Liu
    Han Zeng
    Kaifeng Jin
    Yanze Yu
    Runze You
    Hongyi Zhang
    Chunnan Liu
    Xiaohe Su
    Sen Yan
    Yuan Chang
    Li Liu
    Le Xu
    Jiejie Xu
    Yu Zhu
    Zewei Wang
    British Journal of Cancer, 2022, 126 : 1310 - 1317
  • [4] NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
    Yan, Sen
    Zeng, Han
    Jin, Kaifeng
    Shao, Fei
    Liu, Zhaopei
    Chang, Yuan
    Wang, Yiwei
    Zhu, Yu
    Wang, Zewei
    Xu, Le
    Xu, Jiejie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
  • [5] Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
    Xiaohe Su
    Kaifeng Jin
    Qiji Guo
    Ziyue Xu
    Zhaopei Liu
    Han Zeng
    Yiwei Wang
    Yu Zhu
    Le Xu
    Zewei Wang
    Yuan Chang
    Jiejie Xu
    British Journal of Cancer, 2024, 130 : 852 - 860
  • [6] Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
    Su, Xiaohe
    Jin, Kaifeng
    Guo, Qiji
    Xu, Ziyue
    Liu, Zhaopei
    Zeng, Han
    Wang, Yiwei
    Zhu, Yu
    Xu, Le
    Wang, Zewei
    Chang, Yuan
    Xu, Jiejie
    BRITISH JOURNAL OF CANCER, 2024, 130 (05) : 852 - 860
  • [7] BLADDER CANCER PD-L1 and BCG response prediction
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2020, 17 (01) : 8 - 8
  • [8] POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1
    Liu, Ge
    Jin, Kaifeng
    Liu, Zhaopei
    Su, Xiaohe
    Xu, Ziyue
    Li, Bingyu
    Xu, Jingtong
    Chang, Yuan
    Wang, Yiwei
    Zhu, Yu
    Xu, Le
    Xu, Jiejie
    Wang, Zewei
    Liu, Hailong
    Zhang, Weijuan
    CANCER MEDICINE, 2024, 13 (04):
  • [9] Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
    Huang, Kevin Chih-Yang
    Chiang, Shu-Fen
    Chen, William Tzu-Liang
    Chen, Tsung-Wei
    Hu, Ching-Han
    Yang, Pei-Chen
    Ke, Tao-Wei
    Chao, K. S. Clifford
    CANCERS, 2020, 12 (02)
  • [10] PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer
    Polak, Paz
    Fu, Lili
    Foulkes, William D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (09): : 866 - 868